Document Detail

Expression and Function of Ephrin-B1 and Its Cognate Receptor EphB2 in Human Abdominal Aortic Aneurysm.
Jump to Full Text
MedLine Citation:
PMID:  22830028     Owner:  NLM     Status:  PubMed-not-MEDLINE    
We examined the expression of ephrin-B1 and its cognate receptor EphB2, key regulators of angiogenesis and embryogenesis, in human abdominal aortic aneurysm (AAA) and analyzed their functional roles in cell migration. From 10 patients (9 males and 1 female; age, 68.5 ± 2.4) who underwent vascular surgery for AAA, we obtained AAA and adjacent control tissues. Using real-time RT-PCR, we analyzed expression of ephrin-B1 and EphB2. We also histologically localized these molecules in AAA tissues. Finally, effects of ephrin-B1 and EphB2 on inflammatory cell chemotaxis were examined by cell migration assay. Expression levels of ephrin-B1 (0.410 ± 0.046 versus 1.198 ± 0.252, P = 0.027) and EphB2 (0.764 ± 0.212 versus 1.272 ± 0.137, P = 0.594) were higher in AAA than normal control. Both ephrin-B1 and EphB2 were expressed in macrophages, T lymphocytes, and endothelial cells within AAA. In chemotaxis assay, ephrin-B1 and EphB2 inhibited mononuclear-cell chemotaxis induced by stromal derived factor-1 down to 54.7 ± 12.7% (P = 0.01) and 50.7 ± 13.1% (P = 0.01), respectively. These data suggest that ephrin-B1 and EphB2 might be functional in human adult inflammatory cells and involved in the pathogenesis of AAA, although specific roles of these molecules should further be sought.
Aiji Sakamoto; Masaaki Kawashiri; Hatsue Ishibashi-Ueda; Yuka Sugamoto; Tsuyoshi Yoshimuta; Takeo Higashikata; Hitoshi Ogino; Hayato Tada; Tetsuo Konno; Kenshi Hayashi; Masakazu Yamagishi
Related Documents :
22407918 - Enhancing immunostimulatory function of human embryonic stem cell-derived dendritic cel...
16478598 - Male germ cell transplantation in livestock.
18371438 - Stem cell defects in atm-deficient undifferentiated spermatogonia through dna damage-in...
15172978 - Disappearance of the telomere dysfunction-induced stress response in fully senescent ce...
9108388 - The characterization, molecular cloning, and expression of a novel hematopoietic cell a...
12759418 - Genetic dissection of v alpha 14j alpha 18 natural t cell number and function in autoim...
Publication Detail:
Type:  Journal Article     Date:  2012-07-05
Journal Detail:
Title:  International journal of vascular medicine     Volume:  2012     ISSN:  2090-2832     ISO Abbreviation:  Int J Vasc Med     Publication Date:  2012  
Date Detail:
Created Date:  2012-07-25     Completed Date:  2012-08-23     Revised Date:  2013-04-01    
Medline Journal Info:
Nlm Unique ID:  101542608     Medline TA:  Int J Vasc Med     Country:  United States    
Other Details:
Languages:  eng     Pagination:  127149     Citation Subset:  -    
Department of Vascular Physiology, National Cerebral and Cardiovascular Center, Suita, Osaka 565-8565, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Full Text
Journal Information
Journal ID (nlm-ta): Int J Vasc Med
Journal ID (iso-abbrev): Int J Vasc Med
Journal ID (publisher-id): IJVM
ISSN: 2090-2824
ISSN: 2090-2832
Publisher: Hindawi Publishing Corporation
Article Information
Download PDF
Copyright © 2012 Aiji Sakamoto et al.
Received Day: 29 Month: 3 Year: 2012
Revision Received Day: 22 Month: 5 Year: 2012
Accepted Day: 6 Month: 6 Year: 2012
Print publication date: Year: 2012
Electronic publication date: Day: 5 Month: 7 Year: 2012
Volume: 2012E-location ID: 127149
ID: 3398656
PubMed Id: 22830028
DOI: 10.1155/2012/127149

Expression and Function of Ephrin-B1 and Its Cognate Receptor EphB2 in Human Abdominal Aortic Aneurysm
Aiji Sakamoto1
Masaaki Kawashiri2
Hatsue Ishibashi-Ueda3
Yuka Sugamoto1
Tsuyoshi Yoshimuta1
Takeo Higashikata1
Hitoshi Ogino4
Hayato Tada2
Tetsuo Konno2
Kenshi Hayashi2
Masakazu Yamagishi2*
1Department of Vascular Physiology, National Cerebral and Cardiovascular Center, Suita, Osaka 565-8565, Japan
2Division of Cardiovascular Medicine, Kanazawa University Graduate School of Medicine, Kanazawa, Ishikawa 920-8640, Japan
3Department of Pathology, National Cerebral and Cardiovascular Center, Suita, Osaka 565-8565, Japan
4Cardiovascular Surgery, National Cerebral and Cardiovascular Center, Suita, Osaka 565-8565, Japan
Correspondence: *Masakazu Yamagishi:
[other] Academic Editor: Muredach P. Reilly

1. Introduction

Abdominal aortic aneurysm (AAA) has high risk for aortic rupture and constitutes one of the major causes of elderly death [1], sometimes being associated with coronary ectasia [2]. Compared to occlusive atherosclerosis such as carotid atheroma, AAA affects much more extensive layers of blood vessels but shares some pathogenic aspects such as inflammatory cell accumulation [3]. Genetically engineered mouse models for AAA have elucidated key molecules for the pathogenesis of AAA [4]. For example, some matrix metalloproteinases (MMPs) are upregulated and expressed in macrophages within AAA, which is likely to cause medial degeneration in AAA [5] with or without physiological stress such as hypoxia [6]. However, our understanding on the molecular and cellular pathogenesis of AAA is still limited, especially in cases of humans.

Recently, we have found that ephrin-B1 and its cognate receptor EphB2, the key regulators of angiogenesis and embryogenesis, are upregulated and predominantly expressed in macrophages and T-lymphocytes in human carotid atherosclerotic plaque [6]. Ephrin-B1 and EphB2 belong to ephrin and Eph family of genes consisting 21 members, which are expressed ubiquitously in embryonic tissues and involved in morphogenesis by regulating cell adhesion and migration [7, 8]. Therefore, we hypothesized that ephrin-B1 and EphB2 might be also involved in the pathogenesis of AAA and set out to analyze the expression of these molecules in human AAA and their modulatory effects on chemotaxis of inflammatory cells.

2. Methods
2.1. Patients

The experimental protocol complied with the principles of the Declaration of Helsinki and was approved by the ethical committee of National Cerebral and Cardiovascular Center. Written informed consent was obtained from all the 10 patients who underwent elective graft replacement surgery for AAA (9 males and 1 female; age, 68.5 ± 2.4) [9]. None of the AAA patients suffered from clinically unstable state such as aortic rupture before surgery. The diameter of AAA measured by computed tomography ranged from 38 to 80 mm (55.3 ± 3.5 mm). The prevalence of risk factors for AAA was as follows: hypertension in 9, hyperlipidemia in 8, smoking in 7, and diabetes mellitus in 2 out of 10 patients.

2.2. Aortic Tissue Sampling

During graft replacement for AAA, a strip of aortic wall that contained the dilated region and lacked mural thrombus was carefully excised. An infra-renal aortic strip which contained minimal atherosclerotic changes without dilation was also obtained from five patients as control. All the samples were quickly frozen in liquid nitrogen and stored at −80°C until extraction of RNA. A part of the tissue was fixed with non-formalin-fixative solution, Histochoice (Amresco, Solon, OH), and embedded in paraffin.

2.3. Antibodies and Reagents

For immunohistochemistry, we used the following mouse monoclonal antibodies: anti-CD68 (clone KP1) (Dako, Glostrup, Denmark) and anti-CD8 (clone 4B11) (Novocastra, Newcastle, UK). The following polyclonal antibodies were employed: rabbit anti-ephrin-B1 (Santa Cruz, Santa Cruz, CA); goat anti-EphB2 (Sigma, St. Louis, MO); rabbit anti-von Willebrand Factor (vWF) (Dako); rabbit anti-CXCR-4 (Sigma-Aldrich, St. Louis, MO). Biotinylated swine anti-goat IgG (Dako) was also used. The following recombinant proteins were used: human stromal-derived factor-1 (SDF-1) (PeproTech, London, UK); human monocyte chemotactic protein-1 (MCP-1) (BioLegend, San Diego, CA); mouse ephrin-B1-IgG-Fc chimera and mouse EphB2-IgG-Fc chimera (R&D Systems, Minneapolis, MN); IgG-Fc (Athens Research & Technology, Athens, GA).

2.4. Quantitative Reverse Transcription-Polymerase Chain Reaction (Quantitative RT-PCR)

Total RNA was isolated from the aortic specimens using Isogen reagent (Nippon Gene, Tokyo, Japan) according to the manufacturer's instructions [10]. Concentration of the RNA was measured with spectrophotometer and its integrity was confirmed visually on 1.2% denaturing agarose gel electrophoresis stained with SYBR Green dye (Invitrogen, Carsbad, CA). Then, 10 μg of total RNA was treated with DNA-free agent (Ambion, Austin, TX) and converted to cDNA using random primers and SuperScript II reverse transcriptase (Invitrogen). Quantitative RT-PCR was performed using TaqMan reagents on ABI Prism 7700 Sequence Detection System (PE Applied Biosystems, Foster City, CA). Assay-on-Demand cocktails (PE Applied Biosystems) were used for ephrin-B1 (Hs00270004_m1) and EphB2 (Hs00362096_m1). For GAPDH, predeveloped TaqMan assay reagent was used. The expression levels of ephrin-B1 or EphB2 were normalized to those of GAPDH as described previously [5, 11].

2.5. Immunohistochemistry

The paraffin-embedded specimens of AAA were sectioned in 3 μmthickness. These sections were deparaffinized with Neo-Clear (Merk, Darmsdat, Germany). For histopathological evaluation, the sections were stained with hematoxylin and eosin (H&E). For double immunohistochemical staining of ephrin-B1 and CD68, ephrin-B1 and CD8, ephrin-B1 and vWF, or ephrin-B1 and CXCR-4, the sections were first incubated with anti-ephrin-B1 antibody (1 : 300 dilution) and indirectly stained as brown precipitates using peroxidase-coupled Envision system (PO-Envision, Dako) and 3, 3′-diaminobenzidine (DAB) as substrate. Subsequently, the same sections were incubated with anti-CD68 (1 : 300 dilution), anti-CD8 (1 : 40 dilution), anti-vWF (1 : 200 dilution), or anti-CXCR4 (1 : 100 dilution) antibodies and stained as red precipitates using alkaline phosphatase-coupled Envision system (AP-Envision, Dako) and New Fuchsin (Dako) as substrate.

For double immunostaining of EphB2 and CD68, EphB2 and CD8, EphB2 and vWF, or EphB2 and CXCR-4, sections were first incubated with goat anti-EphB2 antibody (1 : 50 dilution) and processed with peroxidase-coupled Histofine MAX-(G) system (Nichirei, Tokyo, Japan) and DAB. The same sections were then incubated with anti-CD68, anti-CD8, anti-vWF, or anti-CXCR4 antibodies and processed with AP-Envision and New Fuchsin. Before the double immunohistochemistry for ephrin-B1 and CD8 or EphB2 and CD8, the sections had been autoclaved in 0.01 mol/L citrate buffer (pH 6.0) for 5 minutes at 121°C to unmask CD8 antigen. For double immunostaining of CD68 and CXCR-4, the sections were first incubated with anti-CD68 antibody and processed with PO-Envision and DAB. The same sections were then incubated with anti-CXCR-4 antibody and processed with AP-Envision and New Fuchsin. All these preparations were counterstained with hematoxylin, mounted with Neo-Mount (Merk), and examined with Axiophot2 light microscope equipped with AxioCam CCD camera (Carl Zeiss, Hallbergmoos, Germany).

2.6. RT-PCR for Ephrin-B1 and EphB2 in Peripheral Blood Mononuclear Cells

Human peripheral blood mononuclear cells (PBMC) were prepared from forearm venous blood of healthy adult volunteers by density-gradient centrifugation through Lymphoprep (Axis-Shield PoC AS, Oslo, Norway). From the human PBMC, total RNA was isolated with Isogen reagent, which was cleared of contaminating genomic DNA and reversely transcribed to cDNA using QuantiTect Reverse Transcription Kit (Qiagen, Hilden, Germany). For RT-PCR, the forward and reverse primers were designed within a single exon  of  ephrin-B1  (exon  5)  or  EphB2  (exon  6) : ephrin-B1, 5′-GTCCTACTACTGAAGCTACG-3′/5′-CTCTTGGACGATGTAGACAG-3′;  EphB2, 5′-GCAGTGTCCATCATGCATC-3′/5′-AGTACTGCAGCTCATAGTCC-3′.

As negative and positive controls, the DNA-cleared RNA without reverse transcription and human genomic DNA (50 nM; Clontech, Palo Alto, CA) were used, respectively. The reaction mixture was assembled to a total volume of 10 μL as follows: 6.65 μL water, 1.0 μL 10 × Ex Taq buffer, 0.8 μL dNTP mixture (comprising 2.5 mM of each nucleotide), 1.0 μL forward and reverse primer mixture (5 μM of each primer), 0.5 μL template, and 0.05 μL Ex Taq polymerase (TaKaRa, Tokyo, Japan). The PCR was carried out with preheating (94°C for 2 min) and 35 cycles of amplification (94°C for 20 s, 60°C for 30 s and 72°C for 40 s). The PCR products were subjected to acrylamide gel electrophoresis and stained with Ethidium bromide. The experiments were performed at least three times and the representative data are shown.

2.7. Cell Migration Assay

Boyden chamber cell migration assay was performed using 24-well Transwell plates which contain, in each well, a chamber with 5 μm porous polycarbonate membrane separating the well into upper and lower parts (Corning, Corning, NY). The chamber membranes were precoated with ephrin-B1-Fc, EphB2-Fc, or IgG-Fc as control (5 μg/mL, overnight). Then the chambers were inserted into Transwell plates containing 600 μL of assay buffer (RPMI1640 medium with 0.1% heat-inactivated BSA) with or without chemokines (SDF-1 or MCP-1 at 0.1 μg/mL). Human PBMC (1 × 105 cells in 100 μL of the assay buffer) were loaded into the chamber and allowed to migrate down to the lower part of the well for 2 hours in a humidified incubator (37°C; 5% CO2). After the migration period, the PBMC that had passed down through the membrane were collected and counted using Z2 Coulter counter (Beckman Coulter, Fullerton, CA). Under the same condition, we also tried to use soluble recombinant ephrin-B1 and EphB2 diluted into the medium to assess the cell migration, because there were some reports that demonstrated differences in results of cell migration [12].

2.8. Statistical Analysis

The results of Quantitative RT-PCR and Boyden chamber assay were expressed as mean ± SEM of two independent experiments done in triplicate. All statistical analyses were performed by using StatView Ver.5.0 software (SAS Institute Inc, Cary, NC). A value of P < 0.05 was considered to be statistically significant.

3. Results
3.1. Expression of Ephrin-B1 and EphB2 in Human AAA

All the total RNA isolated from AAA or control aortas maintained robust integrity on agarose gel electrophoresis, ensuring reliable analysis of gene expression. Quantitative real-time RT-PCR showed that ephrin-B1 was significantly upregulated in AAA than in control (Figure 1). As for EphB2, a trend toward higher expression in AAA was observed, although the data did not reach statistical significance.

3.2. Immunohistochemical Analysis of Ephrin-B1 and EphB2 in Human AAA Lesions

Each of the tissue specimens used in this study showed typical structures of AAA. All the layers of aorta were affected and the tunica media were severely damaged (Figure 2(a)). Prominent fatty streaks and inflammatory cell infiltration were observed in the intima (Figure 2(b)). Under these conditions, the presence of these inflammatory cells was apparently greater in AAA tissues than those in controls. We performed double immunohistochemical staining to clarify the precise cell types expressing ephrin-B1 or EphB2 therein, because we found that ephrin-B1 and EphB2 were expressed in various types of cells within human AAA with single immunostaining.

Immunoreactivity of ephrin-B1 was found in the following cell types: macrophages positive for CD68 [13] (Figure 2(c)); lymphocytes positive for CD8 [14] (Figure 2(d)); endothelial cells positive for vWF [15] (Figure 2(e)). Similarly, EphB2 was detected in macrophages positive for CD68 (Figure 3(a)), lymphocytes positive for CD8 (Figure 3(b)), and endothelial cells positive for vWF (Figure 3(c)).

To investigate functional significance of ephrin-B1 and EphB2 on chemotaxis of macrophages or lymphocytes, we examined coexpression of these molecules with CXCR4, a receptor for SDF-1 [16] by double immunohistochemistry. Many macrophage- or lymphocyte-like cells were found to express both ephrin-B1 and CXCR4 (Figure 2(f)) or both EphB2 and CXCR4 (Figure 3(d)).

3.3. Functional Expression of Ephrin-B1 and EphB2 in Peripheral Blood Mononuclear Cells

To confirm the expression at mRNA levels of ephrin-B1 and EphB2 on human adult inflammatory cells, we performed RT-PCR. In human PBMC, both ephrin-B1and EphB2 were robustly expressed (Figure 4). We then tested whether ephrin-B1 and EphB2 have functional importance in human PBMC, by examining the effects of ephrin-B1 and EphB2 on their chemotaxis. In Boyden chamber assay, membrane-coated ephrin-B1-Fc or EphB2-Fc chimeric proteins did not affect spontaneous migration of PBMC (Figure 5(a)). However, the chemotaxis of PBMC induced by SDF-1 was significantly inhibited by ephrin-B1-IgG-Fc and EphB2-IgG-Fc down to 54.7 ± 12.7% (P = 0.01) and 50.7 ± 13.1% (P = 0.01), respectively (Figure 5(b)). Also, MCP-1-induced chemotaxis of PBMC was significantly inhibited by ephrin-B1-IgG-Fc and EphB2-IgG-Fc down to 53.8 ± 10.9% (P = 0.01) and 51.3 ± 11.6% (P = 0.01), respectively, although no significant increases or decreases of cell migration were observed in cases of soluble ephrin-B1 and EphB2.

4. Discussion

We found that both ephrin-B1 and EphB2 exhibited higher expression in human AAA and were expressed in macrophages, T lymphocytes, and endothelial cells therein. Furthermore, we found that membrane-bound ephrin-B1 and EphB2 inhibited chemotaxis of human PBMC in Boyden chamber assay. Ephrins and their cognate receptor Ephs are well-known regulators in embryogenesis [7, 8] but their expressions and pathogenic roles in AAA remain unclear. Therefore, the findings of this study would give us a new clue to investigate the molecular pathogenesis of human AAA.

One major cause of higher expression of ephrin-B1 and EphB2 in AAA is probably the infiltration therein of macrophages and T-lymphocytes expressing these two genes. However, gene expression levels of ephrin-B1 and EphB2 in monocytes/macrophages, T-lymphocytes, and endothelial cells in AAA might be upregulated, which remains to be elucidated. Taken together with the fact that ephrin-A5 is upregulated in human AAA [17], wide spectrum of ephrins and Ephs [7] might be upregulated in human AAA. We further tested whether ephrin-B1 and EphB2 are functional or nonfunctional on human adult inflammatory cells. For this purpose, we examined the effects of ephrin-B1 and EphB2 on chemotaxis, because these molecules are well known to regulate migration of embryonic cells. In Boyden chamber assay, the membrane-fixed ephrin-B1 inhibited chemotaxis of human PBMC induced by SDF-1 or MCP-1, which is in line with the previous reports that ephrin-B1 inhibits SDF-1-induced chemotaxis of Jurkat T-lymphocytic [18] and THP-1 monocytic cell lines [6].

The chemotaxis of human PBMC induced by SDF-1 or MCP-1 was also inhibited by the membrane-fixed EphB2, which usually functions as receptor. This ligand-like action by EphB2 is considered so-called reverse signalling [8], like EphB2 inhibiting SDF-1-dependent migration of cerebellar granule cell of mouse embryo [19]. In addition, there are several reports which show ephrin signalling interacts with inflammatory molecules such as Rho family GTPases [20] and VCAM-1 [21]. Thus, our findings from Boyden chamber assay suggest that ephrin-B1 and EphB2 on human PBMC are functional.

Importantly, these inhibitory effects of ephrin-B1 and EphB2 were not clearly observed when we used soluble agents. This may be partially explained by a dependence of Eph receptor activation on lateral movement across the cell membrane for complete activity [12]. Pfaff et al. [22] demonstrated lateral movement of endothelial ephrinB2 from the apical surface to cell-cell junctions preceding degradation. Additionally, one might speculate that ephrins/eph receptors fixed to transwell membranes may not induce proper spatial distribution of counter-receptors/ligands for chemotaxis. However, the present data demonstrate at least the inhibitory effects of cell migration induced by SDF-1 in vitro.

Including cytokines and chemokines, most of the known factors that regulate the activities of macrophages or T-lymphocytes are soluble molecules which are widely spread [23]. In contrast, ephrins and Ephs are membrane-bound molecules which exert their functions locally through cell-to-cell interaction with their neighbouring cells [24]. During the pathological courses of many inflammatory diseases including AAA [2529], various types of cell-to-cell interaction occur: macrophages-to-macrophages, macrophages-to-T-lymphocytes, macrophages-to-endothelial cells, and so on. Ephrin-B1 and EphB2, or more generally ephrins and Ephs, might locally and precisely modulate the activities of macrophages and T-lymphocytes conditioned by diffusing factors such as cytokines and chemokines. Understanding the effect of ephrinB1 or EphB2 activation on the inflammatory condition, perhaps to MMP expression or function, may make clear the role of ephrinB1 or EphB2 in this context [30]. Interestingly, we recently found that ephrin and Eph family are widely expressed in atherosclerosis-related cells in human [31]. Further study will elucidate the in vivo roles of ephrins and Ephs in the development of atherosclerosis, both dilated and occlusive, and other inflammatory diseases.

5. Conclusions

This study suggests that ephrin-B1 and EphB2, the key embryogenic regulators, might be involved in the molecular and cellular pathogenesis of human AAA. Through cell-to-cell interactions, ephrin-B1 and EphB2 might locally modulate the inflammatory cell activities conditioned by soluble mediators such as cytokines. Ephrin/Eph system, the largest receptor tyrosine kinase system in the human genome, may give us a clue to unravel yet unknown pathogenesis of AAA and to devise novel therapeutic strategies for AAA and other inflammatory diseases, although specific roles of these molecules in the development of AAA should further be sought.

Conflict of Interests

The authors declare that they have no conflict of interests.

1. Tilson MD 3rd. The polymorphonuclear leukocyte and the abdominal aortic aneurysm: a neglected cell type and a neglected diseaseCirculationYear: 200511221541562-s2.0-2214448009316009807
2. Triantafyllidi H,Rizos I,Rallidis L,et al. Aortic distensibility associates with increased ascending thoracic aorta diameter and left ventricular diastolic dysfunction in patients with coronary artery ectasiaHeart and VesselsYear: 20102531871942-s2.0-7795615158120512445
3. Shimizu K,Mitchell RN,Libby P. Inflammation and cellular immune responses in abdominal aortic aneurysmsArteriosclerosis, Thrombosis, and Vascular BiologyYear: 20062659879942-s2.0-33646449061
4. Daugherty A,Cassis LA. Mouse models of abdominal aortic aneurysmsArteriosclerosis, Thrombosis, and Vascular BiologyYear: 20042434294342-s2.0-1542283777
5. Higashikata T,Yamagishi M,Sasaki H,et al. Application of real-time RT-PCR to quantifying gene expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human abdominal aortic aneurysmAtherosclerosisYear: 200417723533602-s2.0-864422694715530910
6. Sakamoto A,Ishibashi-Ueda H,Sugamoto Y,et al. Expression and function of ephrin-B1 and its cognate receptor EphB2 in human atherosclerosis: from an aspect of chemotaxisClinical ScienceYear: 2008114106436502-s2.0-4254910315718092944
7. Palmer A,Klein R. Multiple roles of ephrins in morphogenesis, neuronal networking, and brain functionGenes and DevelopmentYear: 20031712142914502-s2.0-003804620212815065
8. Pasquale EB. Eph receptors and ephrins in cancer: bidirectional signalling and beyondNature Reviews CancerYear: 20101031651802-s2.0-77649114060
9. Rose J. Stent-grafts for unruptured abdominal aortic aneurysms: current statusCardioVascular and Interventional RadiologyYear: 20062933323432-s2.0-3364576374516502163
10. Sakamoto A,Ono K,Abe M,et al. Both hypertrophic and dilated cardiomyopathies are caused by mutation of the same gene, δ-sarcoglycan, in hamster: an animal model of disrupted dystrophin-associated glycoprotein complexProceedings of the National Academy of Sciences of the United States of AmericaYear: 1997942513873138782-s2.0-00314719569391120
11. Higashikata T,Yamagishi M,Higashi T,et al. Altered expression balance of matrix metalloproteinases and their inhibitors in human carotid plaque disruption: results of quantitative tissue analysis using real-time RT-PCR methodAtherosclerosisYear: 200618511651722-s2.0-3094445693816039658
12. Salaita K,Nair PM,Petit RS,et al. Restriction of receptor movement alters cellular response: physical force sensing by EphA2ScienceYear: 20103275971138013852-s2.0-7794941266720223987
13. Pulford KAF,Sipos A,Cordell JL,Stross WP,Mason DY. Distribution of the CD68 macrophage/myeloid associated antigenInternational ImmunologyYear: 19902109739802-s2.0-00251692082078523
14. Hogquist KA,Xing Y. Why CD8+ T cells need diversity when growing upImmunityYear: 2010321562-s2.0-7454918592920152164
15. Ruggeri ZM. The role of von Willebrand factor in thrombus formationThrombosis ResearchYear: 2007120supplement 1S5S92-s2.0-3424988986417493665
16. Hirbe AC,Morgan EA,Weilbaecher KN. The CXCR4/SDF-1 chemokine axis: a potential therapeutic target for bone metastases?Current Pharmaceutical DesignYear: 20101611128412902-s2.0-7795088202020166978
17. Armstrong PJ,Johanning JM,Calton WC Jr.,et al. Differential gene expression in human abdominal aorta: aneurysmal versus occlusive diseaseJournal of Vascular SurgeryYear: 20023523463552-s2.0-003648425711854734
18. Sharfe N,Freywald A,Toro A,Dadi H,Roifman C. Ephrin stimulation modulates T cell chemotaxisEuropean Journal of ImmunologyYear: 20023212374537552-s2.0-003691864412516569
19. Lu Q,Sun EE,Klein RS,Flanagan JG. Ephrin-B reverse signaling is mediated by a novel PDZ-RGS protein and selectively inhibits G protein-coupled chemoattractionCellYear: 2001105169792-s2.0-003581530511301003
20. Klein R. Eph/ephrin signaling in morphogenesis, neural development and plasticityCurrent Opinion in Cell BiologyYear: 20041655805892-s2.0-444422712415363810
21. Eizawa T,Ikeda U,Murakami Y,et al. Increase in circulating endothelial progenitor cells after aortic aneurysm repairHeart and VesselsYear: 20041931071102-s2.0-304260793215168056
22. Pfaff D,Héroult M,Riedel M,et al. Involvement of endothelial ephrin-B2 in adhesion and transmigration of EphB-receptor-expressing monocytesJournal of Cell ScienceYear: 200812122384238502-s2.0-5954908869118957513
23. Kepler TB,Chan C. Spatiotemporal programming of a simple inflammatory processImmunological ReviewsYear: 200721611531632-s2.0-3394720161617367341
24. Janes PW,Adikari S,Lackmann M. Eph/ephrin signalling and function in oncogenesis: lessons from embryonic developmentCurrent Cancer Drug TargetsYear: 2008864734892-s2.0-5134914405618781894
25. Bouloumié A,Curat CA,Sengenès C,Lolmède K,Miranville A,Busse R. Role of macrophage tissue infiltration in metabolic diseasesCurrent Opinion in Clinical Nutrition and Metabolic CareYear: 2005843473542-s2.0-2084446027915930956
26. Grip O,Janciauskiene S,Lindgren S. Macrophages in inflammatory bowel diseaseCurrent Drug TargetsYear: 2003221551602-s2.0-064231413914561168
27. Hendriks JJA,Teunissen CE,de Vries HE,Dijkstra CD. Macrophages and neurodegenerationBrain Research ReviewsYear: 20054821851952-s2.0-1784438101015850657
28. Ma Y,Pope RM. The role of macrophages in rheumatoid arthritisCurrent Pharmaceutical DesignYear: 20051155695802-s2.0-1404427150715720276
29. O’Donnell R,Breen D,Wilson S,Djukanovic R. Inflammatory cells in the airways in COPDThoraxYear: 20066154484542-s2.0-3364655453116648353
30. Lin KT,Sloniowski S,Ethell DW,Ethell IM. Ephrin-B2-induced cleavage of EphB2 receptor is mediated by matrix metalloproteinases to trigger cell repulsionJournal of Biological ChemistryYear: 20082834328969289792-s2.0-5764922100018713744
31. Sakamoto A,Sugamoto Y,Tokunaga Y,et al. Expression profiling of the ephrin (EFN) and Eph receptor (EPH) family of genes in atherosclerosis-related human cellsJournal of International Medical ResearchYear: 20113925225272-s2.0-7995566979921672356

Article Categories:
  • Clinical Study

Previous Document:  Analysis on the incidence of the fibularis quartus muscle using magnetic resonance imaging.
Next Document:  A Model of Left Ventricular Dysfunction Complicated by CAWS Arteritis in DBA/2 Mice.